Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a report issued on Tuesday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Price Performance

AVGR stock opened at $0.47 on Tuesday. The company has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. The business has a fifty day simple moving average of $0.53 and a 200-day simple moving average of $0.77. Avinger has a 52 week low of $0.36 and a 52 week high of $4.37.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.